How do lifestyle factors and exposure to environmental substances affect our cancer risk?
Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
A study presented at SNM's 57th Annual Meeting suggests that medication ingested to control blood-sugar levels can skew the results of cancer screenings using positron emission tomography (PET), a molecular imaging technique, by increasing absorption in the gut of the PET imaging agent called fluorodeoxyglucose (18F- FDG), which mimics sugar inside the body.
Cancer-related fatigue is often a major problem for cancer patients, beginning at diagnosis, during treatment and after completing therapy. Researchers at Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) recently completed a study testing methylphenidate in the treatment of cancer-related fatigue and found that, while it did not improve fatigue for a broad group of patients, the data did not rule out a benefit for those with stage III/IV cancer.
Researchers detail in 'Consideration of the food environment in cancer risk reduction,' new data in obesity. According to a study from the United States, Recently, there has been increased attention to the food environment's impact on chronic disease, specifically obesity and cardiovascular disease.
A new way to deliver cancer-fighting drugs using tiny particles made from lipids and chemotherapy drugs may have the power to knock out malignancies with a one-two punch. The strategy holds promise for patients with many different kinds of cancers.
Epeius Biotechnologies Corporation (www.epeiusbiotech.com) announces the results of the clinical study entitled Phase I and II Studies of Intravenous Rexin-G as Monotherapy for Gemcitabine-resistant Metastatic Pancreas Cancer at the ASCO Annual Meeting on June 6, 2010. The presentation will be discussed by Dr. Howard W. Bruckner, Bruckner Oncology, New York, NY.
A few years ago a thirsty Angela Cunningham walked into a convenience store and was disappointed in her choices for a drink. She saw the row of fountain drinks and coolers of other bottled options and wondered about health aspects of them all. She would look at the ingredient list on the labels and found sugars, artificial sweeteners or preservatives and additives she didn't want.
Few people are taking advantage of pills that have been proven to prevent a substantial number of common cancers. If you didn't realize such pills exist, you are not unusual. Which is part of the problem. This barely used arsenal in the war on cancer has grown to four drugs -- two for the breast and two for the prostate gland. The first won federal approval in 1998; the fourth is now seeking approval.
Carrie Greene's cancer doctor called her on a Saturday morning a few months ago and said he wanted to change her chemotherapy treatment. What do you think about losing your hair, he asked. Greene, 41, who has recurring breast cancer, had already been through that. Twice. One of the worst -- or funniest -- moments came when her 5-year-old daughter yanked off her wig in front of all the kids at day care.
Researchers from Cold Spring Harbor Laboratory in the USA have developed a powerful new technique for analyzing the genome of single tumor cells. The breakthrough allows them to study in fine detail the biology of how tumors develop and has the potential to help doctors identify dangerous tumor cells from small samples such as fine-needle biopsies from the prostate or a non-invasive lesion in the breast,
A new study, 'Utility of influenza vaccination for oncology patients,' is now available. Every fall and winter, patients with cancer and their families ask oncologists whether they should be vaccinated for influenza. This season, with escalating concerns regarding the novel H1N1 influenza virus and its recently approved vaccine, this question has become more frequent and increasingly urgent, scientists in the United States report.
We care about your feedback. Let us know how we can improve your CancerCompass experience.